BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ramia JM. Hilar cholangiocarcinoma. World J Gastrointest Oncol 2013; 5(7): 113-114 [PMID: 23919104 DOI: 10.4251/wjgo.v5.i7.113]
URL: https://www.wjgnet.com/1948-5204/full/v5/i7/113.htm
Number Citing Articles
1
Takahiro Tsuchikawa, Satoshi Hirano, Keisuke Okamura, Joe Matsumoto, Eiji Tamoto, Soichi Murakami, Toru Nakamura, Yuma Ebihara, Yo Kurashima, Toshiaki Shichinohe. Advances in the surgical treatment of hilar cholangiocarcinomaExpert Review of Gastroenterology & Hepatology 2015; 9(3): 369 doi: 10.1586/17474124.2015.960393
2
Salam Daradkeh. A case series of hilar cholangiocarcinoma: A single surgeon experience over 20-yearsAnnals of Medicine and Surgery 2021; 62: 239 doi: 10.1016/j.amsu.2021.01.059
3
Heidi D. Lehrke, Julie K. Heimbach, Tsung-Teh Wu, Sarah M. Jenkins, Gregory J. Gores, Charles B. Rosen, Taofic Mounajjed. Prognostic Significance of the Histologic Response of Perihilar Cholangiocarcinoma to Preoperative Neoadjuvant Chemoradiation in Liver ExplantsAmerican Journal of Surgical Pathology 2016; 40(4): 510 doi: 10.1097/PAS.0000000000000588
4
Geoffrey W. Krampitz, Thomas A. Aloia. Staging of Biliary and Primary Liver TumorsSurgical Oncology Clinics of North America 2019; 28(4): 663 doi: 10.1016/j.soc.2019.06.007
5
Seung Soo Hong, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi. Left-sided Hepatectomy Leads to Less Postoperative Liver Failure and Comparable Overall Survival to Right-sided Hepatectomy in Type II or IV Perihilar CholangiocarcinomaAnnals of Surgical Oncology 2023; 30(3): 1381 doi: 10.1245/s10434-022-12756-x
6
Matthew J. Weiss, David Cosgrove, Joseph M. Herman, Neda Rastegar, Ihab Kamel, Timothy M. Pawlik. Multimodal treatment strategies for advanced hilar cholangiocarcinomaLangenbeck's Archives of Surgery 2014; 399(6): 679 doi: 10.1007/s00423-014-1219-1
7
Emrullah Birgin, Erik Rasbach, Christoph Reissfelder, Nuh N. Rahbari. A systematic review and meta-analysis of caudate lobectomy for treatment of hilar cholangiocarcinomaEuropean Journal of Surgical Oncology 2020; 46(5): 747 doi: 10.1016/j.ejso.2020.01.023
8
Ying Chen, Zhanshan Cha, Wenzheng Fang, Baohua Qian, Wenlong Yu, Wenfeng Li, Guanzhen Yu, Yong Gao. The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinomaOncotarget 2015; 6(24): 20419 doi: 10.18632/oncotarget.3983
9
Wen Zhang, Zheng-Qiang Yang, Hai-Bin Shi, Shen Liu, Wei-Zhong Zhou, Lin-Bo Zhao. Placement of <sup>125</sup>I seed strands and stents for a type IV Klatskin tumorWorld Journal of Gastroenterology 2015; 21(1): 373-376 doi: 10.3748/wjg.v21.i1.373
10
Dongyun Xu, Wei Yi, Ying Chen, Lijun Ma, Jiejun Wang, Guanzhen Yu. Overexpression of Sig1R is closely associated with tumor progression and poor outcome in patients with hilar cholangiocarcinomaMedical Oncology 2014; 31(12) doi: 10.1007/s12032-014-0261-8
11
Gui‐Li Huang, Wei Zhang, Hong‐Yue Ren, Xue‐Ying Shen, Qing‐Xi Chen, Dong‐Yan Shen. Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β‐catenin and nuclear factor‐κB pathwaysCancer Science 2015; 106(11): 1515 doi: 10.1111/cas.12802
12
Sara Kammerer, Tobias Meister, Heiner Wolters, Matthias Lessing, Anna Hüsing, Dirk Domagk, Martin Floer, Christian Wilms, Hartmut Schmidt, Norbert Senninger, Gabriele Köhler, Hauke Sebastian Heinzow. Preoperative prediction of curative surgery of perihilar cholangiocarcinoma by combination of endoscopic ultrasound and computed tomographyUnited European Gastroenterology Journal 2018; 6(2): 263 doi: 10.1177/2050640617713651
13
A. V. Czhao, T. V. Shevchenko, Yu. O. Zharikov. View of the problem of Rlatskin tumorKhirurgiya. Zhurnal im. N.I. Pirogova 2015; (4): 62 doi: 10.17116/hirurgia2015462-67
14
Da-Xin Sun, Xiao-Dong Tan, Feng Gao, Jin Xu, Dong-Xu Cui, Xian-Wei Dai, Helge Bruns. Use of an Autologous Liver Round Ligament Flap Zeros Postoperative Bile Leak after Curative Resection of Hilar CholangiocarcinomaPLOS ONE 2015; 10(5): e0125977 doi: 10.1371/journal.pone.0125977